Inventor

LI DALIN

US11 patents

⚠️ This page may combine multiple inventors who share the name “LI DALIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CEDARS SINAI MEDICAL CENTER

8 patents

US10626180B2Apr 21, 2020

Methods of treating and predicting non-response to anti-TNF treatment in subjects with inflammatory bowel disease

CEDARS SINAI MEDICAL CENTER16 citations90

US10633449B2Apr 28, 2020

Treatment and reversal of fibrosis and inflammation by inhibition of the TL1A-DR3 signaling pathway

CEDARS SINAI MEDICAL CENTER12 citations84

US11434296B2Sep 6, 2022

Mitigation and reversal of intestinal fibrosis and inflammation by inhibition of TL1A function

CEDARS SINAI MEDICAL CENTER5 citations83

US11180565B2Nov 23, 2021

Method of enriching a target nucleic acid at a TNFRSF1B gene locus in a sample from a subject with inflammatory bowel disease

CEDARS SINAI MEDICAL CENTER3 citations69

US12590160B2Mar 31, 2026

Mitigation and reversal of intestinal fibrosis and inflammation by inhibition of TL1A function

CEDARS SINAI MEDICAL CENTER0 citations61

US12545959B2Feb 10, 2026

PROMETHEUS BIOSCIENCES INC

3 patents

US11136386B2Oct 5, 2021

Methods of treating Crohn's disease or ulcerative colitis by administering inhibitors of tumor necrosis factor-like cytokine 1A (TL1A)

PROMETHEUS BIOSCIENCES INC12 citations82

US12215147B2Feb 4, 2025

Methods of selecting, based on polymorphisms, an inflammatory bowel disease subject for treatment with an anti-TL1A antibody

PROMETHEUS BIOSCIENCES INC1 citations71

US12391752B2Aug 19, 2025

Methods of enriching or amplifying nucleic acids in a sample from a patient with inflammatory bowel disease

PROMETHEUS BIOSCIENCES INC0 citations59

LI DALIN

CEDARS SINAI MEDICAL CENTER

Methods of treating and predicting non-response to anti-TNF treatment in subjects with inflammatory bowel disease

Treatment and reversal of fibrosis and inflammation by inhibition of the TL1A-DR3 signaling pathway

Mitigation and reversal of intestinal fibrosis and inflammation by inhibition of TL1A function

Method of enriching a target nucleic acid at a TNFRSF1B gene locus in a sample from a subject with inflammatory bowel disease

Mitigation and reversal of intestinal fibrosis and inflammation by inhibition of TL1A function

Diagnosis of inflammatory bowel disease based on genes

Kit comprising contiguous nucleobases, including position 76, of RS5745994

Diagnosis of inflammatory bowel disease based on genes

PROMETHEUS BIOSCIENCES INC

Methods of treating Crohn&#39;s disease or ulcerative colitis by administering inhibitors of tumor necrosis factor-like cytokine 1A (TL1A)

Methods of selecting, based on polymorphisms, an inflammatory bowel disease subject for treatment with an anti-TL1A antibody

Methods of enriching or amplifying nucleic acids in a sample from a patient with inflammatory bowel disease

Methods of treating Crohn's disease or ulcerative colitis by administering inhibitors of tumor necrosis factor-like cytokine 1A (TL1A)